3.4.24.71: endothelin-converting enzyme 1
This is an abbreviated version!
For detailed information about endothelin-converting enzyme 1, go to the full flat file.
Word Map on EC 3.4.24.71
-
3.4.24.71
-
endothelins
-
phosphoramidon
-
artery
-
vasoconstrictor
-
endopeptidase
-
cardiovascular
-
hypertension
-
cardiac
-
pulmonary
-
angiotensin
-
neprilysin
-
tone
-
vasoactive
-
metalloprotease
-
vessel
-
coronary
-
phosphoramidon-sensitive
-
metallopeptidases
-
contractile
-
preproet-1
-
vasospasm
-
thiorphan
-
atrial
-
natriuretic
-
pressor
-
ventricular
-
aortic
-
angiotensin-converting
-
preproendothelin-1
-
endothelium-derived
-
et-1-induced
-
insulin-degrading
-
drug development
-
baecs
-
hemodynamic
-
medicine
-
vasopeptidase
-
etb-receptors
-
3.4.24.11
-
metalloendopeptidase
-
subarachnoid
-
chymase
-
conscious
-
ednra
-
sarafotoxin
-
basilar
-
ppet-1
-
21-amino
-
prepro
-
enzyme-2
-
bosentan
-
et-1-mediated
- 3.4.24.71
- endothelins
- phosphoramidon
- artery
-
vasoconstrictor
- endopeptidase
- cardiovascular
- hypertension
- cardiac
- pulmonary
- angiotensin
- neprilysin
-
tone
-
vasoactive
- metalloprotease
- vessel
- coronary
-
phosphoramidon-sensitive
- metallopeptidases
-
contractile
-
preproet-1
- vasospasm
- thiorphan
-
atrial
-
natriuretic
-
pressor
- ventricular
- aortic
-
angiotensin-converting
- preproendothelin-1
-
endothelium-derived
-
et-1-induced
-
insulin-degrading
- drug development
-
baecs
-
hemodynamic
- medicine
-
vasopeptidase
-
etb-receptors
-
3.4.24.11
- metalloendopeptidase
-
subarachnoid
- chymase
-
conscious
-
ednra
- sarafotoxin
-
basilar
-
ppet-1
-
21-amino
-
prepro
- enzyme-2
- bosentan
-
et-1-mediated
Reaction
Hydrolysis of the -Trp21-/-Val- bond in big endothelin to form endothelin 1 =
Synonyms
ECE, ECE-1, ECE-1b, ECE-3, ECE1, endothelin converting enzyme, endothelin converting enzyme-1, Endothelin-converting enzyme, endothelin-converting enzyme 1, endothelin-converting enzyme 1 (ECE-1), endothelin-converting enzyme I, endothelin-converting enzyme-1, endothelin-converting-enzyme-1, ET converting enzyme, hECE-1, More, sECE, solECE-1
ECTree
Advanced search results
Application
Application on EC 3.4.24.71 - endothelin-converting enzyme 1
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
drug development
medicine
-
the enzyme is a target for drug design in cardiovascular disease
drug development
-
ECE-1 is a potential target for the treatment of Alzheimers disease based on its role in amyloid-beta peptide degradation
drug development
-
ECE-1 silencing (RNAi) may be a promising ovarian carcinoma anticancer therapy
drug development
-
Inhibition of endothelin-1 production by ECE-1 is a promising target for the treatment of cardiovascular disease, but lack of substrate specificity is disadvantageous since inhibition of ECE-1 has impact on other pathways too
drug development
-
mixed ACE/ECE-1 inhibitor may lead to vasopeptide inhibitors that can reduce the levels of angiotensin-II and endothelin-1, without interfering with bradykinin cleavage
-
design of new potent and selective inhibitors might eventually lead to drugs against hypertension
medicine
-
elevated plasma levels of endothelin-1 found in several diseases like asthma, hypertension, cerebral vacospasm, congestive heart failure and chronic and acute renal failure, blockade of the ET-1 system could have therapeutic utility
medicine
-
analysis of effect of various ECE inhibitors in myocardial infarction, pulmonary hypertension, arterial hypertension. Overview is given on human studies
medicine
-
ECE-1 is a potential target for RNAi in order to prevent premature delivery
medicine
high enzyme expression independently predicts poor survival of patients with esophageal squamous cell carcinoma
medicine
-
ECE-1 is a potential target for RNAi in order to prevent premature delivery
-